Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever-Reference-Cited by-同舟云学术

Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever

Published:2007-04-01 Issue:7 Volume:64 Page:717-722
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Moores Kevin G.¹

Affiliation:

1. (Clinical) and Director, Division of Drug Information Service, College of Pharmacy, University of Iowa, 100 Oakdale Campus, N330OH, Iowa City, IA 52242-5000

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/64/7/717/28326480/ajhp0717.pdf

Reference20 articles.

1. The Medical Course of Cancer Patients With Fever and Neutropenia

2. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.

3. The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Febrile neutropenia management in cancer patients receiving anti-cancer agents’ treatment: Deepening the search to offer the best care. A critical review follow-up;Critical Reviews in Oncology/Hematology;2020-09

2. Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center;Clinical Lymphoma Myeloma and Leukemia;2019-12

3. Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care;Leukemia & Lymphoma;2015-07-03

4. Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study;Biology of Blood and Marrow Transplantation;2014-07

5. Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma;Biology of Blood and Marrow Transplantation;2013-04